In patients with primary biliary cholangitis, biochemical non-response to obeticholic acid as a second-line therapy may predict an increased risk for clinical events.
Medscape News UK
Source link : https://www.medscape.com/viewarticle/non-response-obeticholic-acid-may-predict-clinical-outcomes-2025a1000pv2?src=rss
Author :
Publish date : 2025-10-03 12:00:00
Copyright for syndicated content belongs to the linked Source.
